Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Abernathy Insider Profile
4 Followers
Robert Abernathy, Chairman & CEO, Director at Avanos Medical, holds 34.17K shares in Avient (Ticker: AVNT), holds 22.29K shares in Haemonetics (Ticker: HAE), holds 80.04K shares in Avanos Medical (Ticker: AVNS).
Robert Abernathy Avanos Medical (AVNS)Chairman & CEO, Director
Avanos Medical (AVNS)
Chairman & CEO, Director
Ranked #54,838 out of 100,285 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-3.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Abernathy holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert Abernathy
Robert Abernathy's Trading History
Avanos Medical
May 03, 2017
Chairman & CEO, Director
Uninformative Sell
725.46K
$1.27M
Haemonetics
Jul 26, 2024
Director
Uninformative Buy
―
$1.78M
Avient
Oct 02, 2024
Director
Uninformative Buy
―
$1.37M
Kimberly Clark
Apr 30, 2014
EVP
Uninformative Sell
2.11M
$10.06M
RS Legacy Corporation
Aug 06, 2013
―
Informative Buy
254.06K
$7.60K
List of latest transactions for each holding click on a transaction to see Robert Abernathy's performance on stock
You May Also Like
Robert Abernathy insider profile FAQ
What is the percentage of profitable transactions made by Robert Abernathy?
The percentage of profitable transactions made by Robert Abernathy is 33%.
What is the average return per transaction made by Robert Abernathy?
The average return per transaction made by Robert Abernathy is -3.70%.
What stocks does Robert Abernathy hold?
Robert Abernathy holds: AVNS, HAE, AVNT, KMB, RSHCQ stocks.
What was Robert Abernathy’s latest transaction?
Robert Abernathy latest transaction was an Uninformative Buy of ―.
What was Robert Abernathy's most profitable transaction?
Robert Abernathy’s most profitable transaction was an Informative Buy of AVNS stock on September 8, 2015. The return on the trade was 16.50%.
What is Robert Abernathy's role in Avanos Medical?
Robert Abernathy's role in Avanos Medical is Chairman & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.